Year: 2024
Type: article
Abstract: The influence of age at diagnosis (dx) on prognosis of MBC patients remains unclear. While recent studies report better overall survival (OS) for younger women, they use primary v. metastatic tumor subtype, lack differentiation of luminal A v. B subtypes, and/or include only de novo patients.
Source: ESMO Open
Authors: K.D. Brantley, G.J. Kirkner, M. Hughes, L. Varella, G. Suggs, O. Cunningham, S. Sammons, A.H. Partridge, N.U. Lin
Institution: Dana-Farber Cancer Institute
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,730
OpenAlex ID: W4397007110